Nan-Horng Lin

Title: Innovations in Pharmacological Science: The Contributions of Nan-Horng Lin

Introduction

Nan-Horng Lin, based in Vernon Hills, Illinois, is an accomplished inventor with an impressive portfolio of 42 patents. His innovations primarily focus on the development of pharmaceutical compounds that target complex biological interactions, paving the way for advancements in the treatment of various diseases.

Latest Patents

Among Lin's most notable contributions are two recent patents. The first patent describes crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(R)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide. This compound acts as an irreversible inhibitor of menin-MLL interaction and shows potential as a treatment for autoimmune diseases, cancers, and inflammatory conditions. The second patent highlights pyrazine compounds that serve as inhibitors of FLT3, outlining methods for using these inhibitors in treating hematological malignancies and other diseases that depend on FLT3 activity.

Career Highlights

Throughout his career, Nan-Horng Lin has made significant contributions in the pharmaceutical sector. He has worked with notable companies such as Abbott Laboratories Corporation and Cho Pharma Inc., where he focused on drug development and innovative therapeutic solutions. His work has had a lasting impact on the industry and the treatment methodologies available for complex diseases.

Collaborations

Lin's achievements have also been enhanced by fruitful collaborations with other professionals in the field. He has worked alongside researchers and scientists like Yun He and Mark W Holladay, contributing to a collaborative environment that fosters innovation and discovery in pharmacology.

Conclusion

Nan-Horng Lin stands out as a prominent inventor whose contributions to pharmaceutical science have the potential to transform treatment options for various diseases. With a robust patent portfolio and notable collaborations, Lin’s work exemplifies the spirit of innovation that drives progress in medical research and therapeutic development.